Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

Related Articles by Review for PubMed (Select 12390103)

1.

Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients.

Lim LL, Wai CT, Lee YM, Kong HL, Lim R, Koay E, Lim SG.

Aliment Pharmacol Ther. 2002 Nov;16(11):1939-44.

2.

Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.

Kohrt HE, Ouyang DL, Keeffe EB.

Aliment Pharmacol Ther. 2006 Oct 1;24(7):1003-16. Review.

3.

Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.

Kohrt HE, Ouyang DL, Keeffe EB.

Clin Liver Dis. 2007 Nov;11(4):965-91, x. Review.

PMID:
17981237
4.
5.

Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy.

Loomba R, Rowley A, Wesley R, Liang TJ, Hoofnagle JH, Pucino F, Csako G.

Ann Intern Med. 2008 Apr 1;148(7):519-28. Review. Erratum in: Ann Intern Med. 2009 May 5;150(9):657-8.

6.

Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis.

Katz LH, Fraser A, Gafter-Gvili A, Leibovici L, Tur-Kaspa R.

J Viral Hepat. 2008 Feb;15(2):89-102. doi: 10.1111/j.1365-2893.2007.00902.x. Review.

PMID:
18184191
7.

[Management of hepatitis B virus reactivation during chemotherapy or immunosuppressive therapy].

Amouri A, Chtourou L, Mnif L, Tahri N.

Presse Med. 2008 Nov;37(11):1591-8. doi: 10.1016/j.lpm.2008.03.011. Epub 2008 Jun 13. Review. French.

PMID:
18555638
8.

Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature.

Zingarelli S, Frassi M, Bazzani C, Scarsi M, Puoti M, Airò P.

J Rheumatol. 2009 Jun;36(6):1188-94. doi: 10.3899/jrheum.081246. Epub 2009 May 15. Review.

PMID:
19447932
9.

Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management.

Lubel JS, Angus PW.

J Gastroenterol Hepatol. 2010 May;25(5):864-71. doi: 10.1111/j.1440-1746.2010.06243.x. Review.

PMID:
20546439
10.
11.

Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature.

Al-Taie OH, Mörk H, Gassel AM, Wilhelm M, Weissbrich B, Scheurlen M.

Ann Hematol. 1999 May;78(5):247-9. Review.

PMID:
10391107
12.

Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy--pathogenesis and management.

Xunrong L, Yan AW, Liang R, Lau GK.

Rev Med Virol. 2001 Sep-Oct;11(5):287-99. Review.

PMID:
11590667
14.

Successful lamivudine therapy for post-chemotherapeutic fulminant hepatitis B in a hepatitis B virus carrier with non-Hodgkin's lymphoma: case report and review of the literature.

Kawai Y, Ikegaya S, Hata M, Kawahito M, Imamura S, Yoshida A, Tsutani H, Ueda T.

Ann Hematol. 2001 Aug;80(8):482-4. Review.

PMID:
11563596
15.
16.

Reactivation of hepatitis B virus associated with chemotherapy and immunosuppressive agent.

Wijaya I, Hasan I.

Acta Med Indones. 2013 Jan;45(1):61-6. Review.

17.

Reactivation of hepatitis B virus in patients receiving chemotherapy.

Ikeda M.

Jpn J Clin Oncol. 2013 Jan;43(1):8-16. doi: 10.1093/jjco/hys191. Epub 2012 Nov 25. Review.

18.

Hepatitis B virus infection and immunosuppressive therapy in patients with inflammatory bowel disease.

Morisco F, Castiglione F, Rispo A, Stroffolini T, Vitale R, Sansone S, Granata R, Orlando A, Marmo R, Riegler G, Vecchi M, Biancone L, Caporaso N.

Dig Liver Dis. 2011 Jan;43 Suppl 1:S40-8. doi: 10.1016/S1590-8658(10)60691-3. Review.

PMID:
21195371
19.

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.

Yeo W, Johnson PJ.

Hepatology. 2006 Feb;43(2):209-20. Review. No abstract available.

PMID:
16440366
20.

Hepatitis B virus infection.

Shayeb J, Soweid A.

J Med Liban. 2001 Mar-Apr;49(2):66-70. Review. No abstract available.

PMID:
11910969
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk